Risk Factors for Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients Treated with Tocilizumab

被引：0

作者：

Rao, Vijay ^{[1
]}

Pavlov, Andrey ^{[2
]}

Klearman, Micki ^{[1
]}

Musselman, David ^{[3
]}

Giles, Jon T. ^{[4
]}

Bathon, Joan M. ^{[4
]}

Sattar, Naveed ^{[5
]}

Lee, Janet S. ^{[3
]}

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

[2] Everest, Toronto, ON, Canada

[3] Roche, Nutley, NJ USA

[4] Columbia Univ, Med Ctr, New York, NY USA

[5] Univ Glasgow, Glasgow, Lanark, Scotland

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1642

引用

页码：S642 / S642

页数：1

共 50 条

[21] Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease
Hageman, Steven H. J.
de Borst, Gert Jan
Dorresteijn, Johannes A. N.
Bots, Michiel L.
Westerink, Jan
Asselbergs, Folkert W.
Visseren, Frank L. J.
HEART, 2020, 106 (21) : 1686 - 1692
[22] Risk factors for cardiovascular events in a population with rheumatoid arthritis
Ayas, SM
Linklater, H
Iveson, JM
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 145 - 146
[23] Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
Dougados, Maxime
Charles-Schoeman, Christina
Szekanecz, Zoltan
Giles, Jon T.
Ytterberg, Steven R.
Bhatt, Deepak L.
Koch, Gary G.
Vranic, Ivana
Wu, Joseph
Wang, Cunshan
Kwok, Kenneth
Menon, Sujatha
Connell, Carol A.
Yndestad, Arne
Rivas, Jose L.
Buch, Maya H.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04) : 575 - 577
[24] IMPACT OF BASELINE CARDIOVASCULAR RISK ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS CLINICAL PROGRAMME
Dougados, M.
Charles-Schoeman, C.
Szekanecz, Z.
Giles, J. T.
Ytterberg, S. R.
Bhatt, D. L.
Koch, G. G.
Vranic, I.
Wu, J.
Wang, C.
Kwok, K.
Menon, S.
Connell, C. A.
Yndestad, A.
Rivas, J. L.
Buch, M. H.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 175 - 176
[25] Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study
Chen, Yen-Ju
Liu, Shih-Chia
Lai, Kuo-Lung
Tang, Kuo-Tung
Lin, Ching-Heng
Chen, Yi-Ming
Tseng, Chih-Wei
Chang, Yu-Mei
Gotcher, Donald F.
Chiou, Chuang-Chun
Weng, Shao-Jen
Chen, Hsin-Hua
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
[26] Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis
Ozen, Gulsen
Pedro, Sofia
Michaud, Kaleb
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (11) : 1487 - 1494
[27] Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs Initiation in Patients with Rheumatoid Arthritis
Ozen, Gulsen
Pedro, Sofia
Michaud, Kaleb
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3274 - 3277
[28] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS AGED ≥50 YEARS WITH RHEUMATOID ARTHRITIS AND ≥1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: A POST HOC ANALYSIS OF ORAL SURVEILLANCE
Charles-Schoeman, C.
Buch, M. H.
Dougados, M.
Bhatt, D. L.
Giles, J. T.
Ytterberg, S. R.
Koch, G. G.
Vranic, I.
Wu, J.
Wang, C.
Menon, S.
Rivas, J. L.
Yndestad, A.
Connell, C. A.
Szekanecz, Z.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 611 - 612
[29] Association Between Lipid Levels and Major Adverse Cardiovascular Events in Rheumatoid Arthritis Compared to Non-Rheumatoid Arthritis Patients
Liao, Katherine P.
Liu, Jun
Lu, Bing
Solomon, Daniel H.
Kim, Seoyoung C.
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2004 - 2010
[30] Adverse events in methotrexate-treated rheumatoid arthritis patients
Sandoval, DM
Alarcon, GS
Morgan, SL
BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 : 49 - 56

← 1 2 3 4 5 →